TVRD
Tvardi Therapeutics
TVRD
TVRD
144 hedge funds and large institutions have $558M invested in Tvardi Therapeutics in 2019 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 49 increasing their positions, 35 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more ownership
Funds ownership: 1.82% → 1.82% (+0%)
0% less capital invested
Capital invested by funds: $559M → $558M (-$576K)
23% less call options, than puts
Call options by funds: $8.31M | Put options by funds: $10.8M
Holders
144
Holding in Top 10
3
Calls
$8.31M
Puts
$10.8M
Top Buyers
| 1 | +$33.6M | |
| 2 | +$21.9M | |
| 3 | +$12.5M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.27M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$8.04M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$10.5M | |
| 3 | -$5.88M | |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
-$5.08M |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$4.42M |